Login / Signup

Experimental Models for Rare Melanoma Research-The Niche That Needs to Be Addressed.

Ioana IonitaDaniel MalitaCristina DeheleanGheorghe Emilian OlteanuIasmina MarcoviciAndreea GeamantanSorin ChiriacAndrea RomanDaniela Radu
Published in: Bioengineering (Basel, Switzerland) (2023)
Melanoma, the tumor arising from the malignant transformation of pigment-producing cells-the melanocytes-represents one of the most severe cancer types. Despite their rarity compared to cutaneous melanoma, the extracutaneous subtypes such as uveal melanoma (UM), acral lentiginous melanoma (ALM), and mucosal melanoma (MM) stand out due to their increased aggressiveness and mortality rate, demanding continuous research to elucidate their specific pathological features and develop efficient therapies. Driven by the emerging progresses made in the preclinical modeling of melanoma, the current paper covers the most relevant in vitro, in vivo, and in ovo systems, providing a deeper understanding of these rare melanoma subtypes. However, the preclinical models for UM, ALM, and MM that were developed so far remain scarce, and none of them is able to completely simulate the complexity that is characteristic to these melanomas; thus, a continuous expansion of the existing library of experimental models is pivotal for driving advancements in this research field. An overview of the applicability of precision medicine in the management of rare melanoma subtypes is also provided.
Keyphrases
  • skin cancer
  • basal cell carcinoma
  • induced apoptosis
  • cardiovascular disease
  • early onset
  • young adults
  • cell proliferation
  • pi k akt